SCHEMBL4252376

SCHEMBL4252376

CCOC(=O)c1c(-c2cccc(NC(=O)O)c2)csc1N1C(=O)c2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
LMNA P02545 9/20 0.49
HPGD P15428 5/20 0.49
MAPT P10636 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
GAA P10253 1/20 0.49
CYP2D6 P10635 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.48
USP2 O75604 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GSTO1 P78417 1/20 0.47
HTT P42858 2/20 0.46
ALOX12 P18054 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4256946 0.89 ALDH1A1 (0.56) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL4757822 0.89 ALDH1A1 (0.47) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL1554259 0.88 ALDH1A1 (0.60) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL1553963 0.87 ALDH1A1 (0.50) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL4259340 0.87 NR1H4 (0.39) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL1553328 0.85 ALDH1A1 (0.48) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL1554495 0.84 PTPN1 (0.52) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL4254043 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL1553441 0.82 ALDH1A1 (0.52) ALDH1A1LMNAHPGDMAPTMEN1
SCHEMBL1553883 0.82 ALDH1A1 (0.55) ALDH1A1LMNAHPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 EP disclosed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 EP disclosed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 WO disclosed